• Establish local capacity for aseptic fill and finish to meet rising demand for sterile biologics
• Accelerate tech transfer initiatives to enable scalable production of complex therapies across regional sites
• Optimize manufacturing processes by adopting best practices in validation and analytical method development
• Mitigate supplier risk by developing regional sourcing strategies and localized supply chain partnerships
• Align with cGMP standards to ensure compliance and global competitiveness in contract manufacturing deals